These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6343556)

  • 1. Tricyclic antidepressants in obsessive-compulsive disorder. Antiobsessional or antidepressant agents?
    Mavissakalian M; Michelson L
    J Nerv Ment Dis; 1983 May; 171(5):301-6. PubMed ID: 6343556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tricyclic antidepressants in obsessive-compulsive disorder: antiobsessional or antidepressant agents? II.
    Mavissakalian M; Turner SM; Michelson L; Jacob R
    Am J Psychiatry; 1985 May; 142(5):572-6. PubMed ID: 3885761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study.
    Flament MF; Rapoport JL; Berg CJ; Sceery W; Kilts C; Mellström B; Linnoila M
    Arch Gen Psychiatry; 1985 Oct; 42(10):977-83. PubMed ID: 3899048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of imipramine on depression and obsessive-compulsive symptoms.
    Foa EB; Steketee G; Kozak MJ; Dugger D
    Psychiatry Res; 1987 Jun; 21(2):123-36. PubMed ID: 3615688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline.
    Insel TR; Murphy DL; Cohen RM; Alterman I; Kilts C; Linnoila M
    Arch Gen Psychiatry; 1983 Jun; 40(6):605-12. PubMed ID: 6342562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-year follow-up after exposure and clomipramine therapy for obsessive compulsive disorder.
    O'Sullivan G; Noshirvani H; Marks I; Monteiro W; Lelliott P
    J Clin Psychiatry; 1991 Apr; 52(4):150-5. PubMed ID: 2016246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of obsessive-compulsive personality disorder in antiobsessional pharmacological treatment.
    Cavedini P; Erzegovesi S; Ronchi P; Bellodi L
    Eur Neuropsychopharmacol; 1997 Feb; 7(1):45-9. PubMed ID: 9088884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clomipramine and imipramine in obsessive-compulsive disorder.
    Volavka J; Neziroglu F; Yaryura-Tobias JA
    Psychiatry Res; 1985 Jan; 14(1):85-93. PubMed ID: 3887445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tricyclic response in obsessive compulsive disorder.
    Insel TR; Mueller EA; Gillin JC; Siever LJ; Murphy DL
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(1):25-31. PubMed ID: 3991911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clomipramine: an antiobsessional tricyclic antidepressant.
    Peters MD; Davis SK; Austin LS
    Clin Pharm; 1990 Mar; 9(3):165-78. PubMed ID: 2180623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients.
    Zohar J; Kaplan Z; Benjamin J
    J Clin Psychiatry; 1993 Oct; 54(10):385-8. PubMed ID: 7903293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.
    Leonard HL; Swedo SE; Rapoport JL; Koby EV; Lenane MC; Cheslow DL; Hamburger SD
    Arch Gen Psychiatry; 1989 Dec; 46(12):1088-92. PubMed ID: 2686576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of clomipramine in treatment of obsessive-compulsive symptomatology.
    Stroebel CF; Szarek BL; Glueck BC
    J Clin Psychopharmacol; 1984 Apr; 4(2):98-100. PubMed ID: 6707247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder.
    Pato MT; Zohar-Kadouch R; Zohar J; Murphy DL
    Am J Psychiatry; 1988 Dec; 145(12):1521-5. PubMed ID: 3057923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug treatment of obsessive-compulsive disorder.
    Zohar J; Insel TR
    J Affect Disord; 1987; 13(2):193-202. PubMed ID: 2960711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
    Piccinelli M; Pini S; Bellantuono C; Wilkinson G
    Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anafranil in obsessive compulsive neurosis.
    Wyndowe J; Solyom L; Ananth J
    Curr Ther Res Clin Exp; 1975 Nov; 18(5):611-7. PubMed ID: 812637
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of obsessive-compulsive neurosis with clomipramine (Anafranil).
    Ananth J
    J Int Med Res; 1977; 5 Suppl 5():38-41. PubMed ID: 598604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiobsessional and antidepressant effects of clomipramine in the treatment of obsessive-compulsive disorder.
    Insel TR; Alterman I; Murphy DL
    Psychopharmacol Bull; 1982 Oct; 18(4):115-7. PubMed ID: 7156271
    [No Abstract]   [Full Text] [Related]  

  • 20. A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
    Jenike MA; Hyman S; Baer L; Holland A; Minichiello WE; Buttolph L; Summergrad P; Seymour R; Ricciardi J
    Am J Psychiatry; 1990 Sep; 147(9):1209-15. PubMed ID: 2143637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.